Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.36 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.33 |
| ▸ | MGAM | O43451 | 3/20 | 0.32 |
| ▸ | GAA | P10253 | 2/20 | 0.32 |
| ▸ | SI | P14410 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24030722 | 1.00 | EPHX1 (0.36) | EPHX1HSD11B1MGAMGAASI | |
| SCHEMBL18291462 | 0.82 | HSD11B1 (0.33) | HSD11B1TSHRALDH1A1CYP3A4 | |
| SCHEMBL8593911 | 0.80 | FUCA1 (0.34) | HSD11B1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL8593912 | 0.80 | FUCA1 (0.34) | HSD11B1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL3163962 | 0.80 | HSD11B1 (0.33) | HSD11B1TSHR | |
| SCHEMBL24030719 | 0.80 | FUCA1 (0.34) | HSD11B1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL196497 | 0.80 | FUCA1 (0.34) | HSD11B1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL5671625 | 0.80 | HSD11B1 (0.33) | HSD11B1TSHR | |
| SCHEMBL887697 | 0.77 | APLNR (0.33) | GAA | |
| SCHEMBL8734687 | 0.77 | GRIN2D (0.36) | HSD11B1ALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2817160-B1 | INJECTION MOULDED DECORATIVE ARTICLE COMPRISING EFFECT PIGMENTS AND MANUFACTURING METHOD | DAIMLER AG (DE) | 2018-03-07 | — | — | EP | claimed |
| EP-2817160-A1 | INJECTION-MOULDED DECORATIVE MOULDED ARTICLE WITH EFFECT PIGMENTS AND MANUFACTURING METHOD | Daimler AG (DE) | 2014-12-31 | — | — | EP | claimed |
| WO-2013123960-A1 | INJECTION-MOULDED DECORATIVE MOULDED ARTICLE WITH EFFECT PIGMENTS AND MANUFACTURING METHOD | DAIMLER AG (DE) | 2013-08-29 | — | — | WO | claimed |
| US-20260139166-A1 | EXPANSION MEDIATED ADHESIVE DEVICE | BVW INVEST AG (CH) | 2026-05-21 | — | — | US | disclosed |
| US-12583973-B2 | Polyimide-based polymer, positive photosensitive resin composition, negative photosensitive resin composition, patterning method, method for forming cured film, interlayer insulating film, surface protective film, and electronic component | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-03-24 | — | — | US | disclosed |
| EP-4615899-A1 | RESIN COMPOSITION FOR PREPARING A THERMOPLASTIC POLYMER MATRIX | Covestro Deutschland AG (DE) | 2025-09-17 | — | — | EP | disclosed |
| US-12384945-B2 | Expansion mediated adhesive device | BVW HOLDING AG (CH) | 2025-08-12 | — | — | US | disclosed |
| US-12180387-B2 | Coating composition | COVESTRO DEUTSCHLAND AG (DE) | 2024-12-31 | — | — | US | disclosed |
| EP-4406986-A1 | RESIN COMPOSITION FOR PREPARING A THERMOPLASTIC POLYMER MATRIX | Covestro Deutschland AG (DE) | 2024-07-31 | — | — | EP | disclosed |
| WO-2024099826-A1 | RESIN COMPOSITION FOR PREPARING A THERMOPLASTIC POLYMER MATRIX | COVESTRO DEUTSCHLAND AG (DE) | 2024-05-16 | — | — | WO | disclosed |
| EP-4267641-A1 | POLYASPARTIC ACID ESTER-CONTAINING COMPOSITION | Covestro Deutschland AG (DE) | 2023-11-01 | — | — | EP | disclosed |
| EP-2817160-A1 | INJECTION-MOULDED DECORATIVE MOULDED ARTICLE WITH EFFECT PIGMENTS AND MANUFACTURING METHOD | Daimler AG (DE) | 2014-12-31 | — | — | EP | disclosed |
| CN-104136232-A | INJECTION-MOULDED DECORATIVE MOULDED ARTICLE WITH EFFECT PIGMENTS AND MANUFACTURING METHOD | DAIMLER AG | 2014-11-05 | — | — | CN | disclosed |
| WO-2013123960-A1 | INJECTION-MOULDED DECORATIVE MOULDED ARTICLE WITH EFFECT PIGMENTS AND MANUFACTURING METHOD | DAIMLER AG (DE) | 2013-08-29 | — | — | WO | disclosed |
| US-20040231561-A1 | Inherently colored polyurea and polyurethane | KAUL BANSI LAL (CH) | 2004-11-25 | — | — | US | disclosed |
| EP-1406941-A1 | INHERENTLY COLORED POLYUREA AND POLYURETHANE | Clariant Finance (BVI) Limited (VG) | 2004-04-14 | — | — | EP | disclosed |
| WO-2003006523-A1 | INHERENTLY COLORED POLYUREA AND POLYURETHANE | CLARIANT INTERNATIONAL LTD. (CH) | 2003-01-23 | — | — | WO | disclosed |
| EP-0136899-B1 | AMORPHOUS SULFOPOLYESTERS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1989-04-19 | — | — | EP | disclosed |
| EP-0136899-A2 | Amorphous sulfopolyesters | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1985-04-10 | — | — | EP | disclosed |
| US-4480085-A | Amorphous sulfopolyesters | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1984-10-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260139166-A1 | EXPANSION MEDIATED ADHESIVE DEVICE | L1CAM, EPCAM, SELL | EPHX1 3485/4885HSD11B1 4831/4885MGAM 2949/4885 |
| US-12583973-B2 | Polyimide-based polymer, positive photosensitive resin composition, negative photosensitive resin composition, patterning method, method for forming cured film, interlayer insulating film, surface protective film, and electronic component | PRDM9, ARCN1, PUF60 | EPHX1 1005/4885HSD11B1 3567/4885MGAM 3816/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.